Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 7, 2014, Pages 2476-2481

  Chen, Juine Ruey ^a   Yu, Yueh Hsiang ^a   Tseng, Yung Chieh ^a,b   Chiang, Wan Ling ^a   Chiang, Ming Feng ^a   Ko, Yi An ^a,c   Chiu, Yi Kai ^a,c   Ma, Hsiu Hua ^a   Wu, Chung Yi ^a   Jan, Jia Tsrong ^a   Lin, Kuo I ^a   Ma, Che ^a   Wong, Chi Huey ^a  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Broadly neutralizing antibody; Glycoprotein engineering

Indexed keywords

BROADLY NEUTRALIZING ANTIBODY; GLYCOPROTEIN ENGINEERING;

ANIMALS; BASE SEQUENCE; CHROMATOGRAPHY, LIQUID; CLONING, MOLECULAR; DRUG DESIGN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FERRETS; FLOW CYTOMETRY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, CELLULAR; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SPECIES SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84894305002     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1323954111     Document Type: Article

References (24)

1. Russell CA, et al. (2008) The global circulation of seasonal influenza A (H3N2) viruses. Science 320(5874):340-346.
2. Bommakanti G, et al. (2010) Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proc Natl Acad Sci USA 107(31):13701-13706.
3. Steel J, et al. (2010) Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1(1):e00018-10.
4. Eckert DM, Kay MS (2010) Stalking influenza. Proc Natl Acad Sci USA 107(31): 13563-13564.
5. Wang TT, et al. (2010) Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci USA 107(44):18979-18984.
6. Kanekiyo M, et al. (2013) Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499(7456):102-106.
7. Wrammert J, et al. (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 208(1): 181-193.
8. Wang TT, et al. (2010) Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog 6(2):e1000796.
9. Corti D, et al. (2010) Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 120(5):1663-1673.
10. Ekiert DC, et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324(5924):246-251.
11. Corti D, et al. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333(6044):850-856.
12. Sui J, et al. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16(3):265-273.
13. Dreyfus C, et al. (2012) Highly conserved protective epitopes on influenza B viruses. Science 337(6100):1343-1348.
14. Ekiert DC, et al. (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333(6044):843-850.
15. Ekiert DC, et al. (2012) Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489(7417):526-532.
16. Yoshida R, et al. (2009) Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog 5(3):e1000350.
17. Wang C-C, et al. (2009) Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc Natl Acad Sci USA 106(43):18137-18142.
18. van Riel D, et al. (2007) Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 171(4):1215-1223.
19. Boni MF (2008) Vaccination and antigenic drift in influenza. Vaccine 26(Suppl 3): C8-C14.
20. Rudneva IA, Ilyushina NA, Timofeeva TA, Webster RG, Kaverin NV (2005) Restoration of virulence of escape mutants of H5 and H9 influenza viruses by their readaptation to mice. J Gen Virol 86(Pt 10):2831-2838.
21. Tsuchiya E, et al. (2002) Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule. J Gen Virol 83(Pt 5):1137-1146.
22. Abe Y, et al. (2004) Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J Virol 78(18): 9605-9611.
23. Chen J-R, Ma C, Wong C-H (2011) Vaccine design of hemagglutinin glycoprotein against influenza. Trends Biotechnol 29(9):426-434.
24. Chen M-W, et al. (2008) A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci USA 105(36): 13538-13543.